CZ20003846A3 - Kompozice pro léčbu zánětlivého onemocnění střev dávkováním N-acetylglukosaminu do tlustého střeva - Google Patents

Kompozice pro léčbu zánětlivého onemocnění střev dávkováním N-acetylglukosaminu do tlustého střeva Download PDF

Info

Publication number
CZ20003846A3
CZ20003846A3 CZ20003846A CZ20003846A CZ20003846A3 CZ 20003846 A3 CZ20003846 A3 CZ 20003846A3 CZ 20003846 A CZ20003846 A CZ 20003846A CZ 20003846 A CZ20003846 A CZ 20003846A CZ 20003846 A3 CZ20003846 A3 CZ 20003846A3
Authority
CZ
Czechia
Prior art keywords
acetylglucosamine
carrier
composition
foam
nag
Prior art date
Application number
CZ20003846A
Other languages
Czech (cs)
English (en)
Inventor
Simon Murch
Ian W. French
Original Assignee
Glucogenics Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glucogenics Pharmaceuticals Inc. filed Critical Glucogenics Pharmaceuticals Inc.
Publication of CZ20003846A3 publication Critical patent/CZ20003846A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
CZ20003846A 1998-04-17 1999-03-12 Kompozice pro léčbu zánětlivého onemocnění střev dávkováním N-acetylglukosaminu do tlustého střeva CZ20003846A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002234936A CA2234936C (fr) 1998-04-17 1998-04-17 Composition pour traiter une affection intestinale inflammatoire par l'administration de n-acetylglucosamine par le colon et traitement connexe

Publications (1)

Publication Number Publication Date
CZ20003846A3 true CZ20003846A3 (cs) 2002-03-13

Family

ID=4162337

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20003846A CZ20003846A3 (cs) 1998-04-17 1999-03-12 Kompozice pro léčbu zánětlivého onemocnění střev dávkováním N-acetylglukosaminu do tlustého střeva

Country Status (8)

Country Link
EP (1) EP1071432A1 (fr)
JP (1) JP2002512195A (fr)
CA (1) CA2234936C (fr)
CZ (1) CZ20003846A3 (fr)
HU (1) HUP0101514A3 (fr)
IL (1) IL139072A0 (fr)
NO (1) NO20005223L (fr)
PL (1) PL343634A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008103345A2 (fr) 2007-02-19 2008-08-28 Marine Polymer Technologies, Inc. Compositions hémostatiques et régimes thérapeutiques
KR101098581B1 (ko) * 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
CN103108638B (zh) 2010-04-15 2016-11-09 海洋聚合物技术公司 聚-n-乙酰葡萄糖胺纳米纤维的抗菌应用
WO2012142581A1 (fr) 2011-04-15 2012-10-18 Marine Polymer Technologies, Inc. Traitement de maladies avec des nanofibres de poly-n-acétylglucosamine
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (fr) * 2013-03-15 2014-09-18 Aihol Corporation Formulation pharmaceutique contenant un glycosaminoglycane
HUE049247T2 (hu) * 2014-11-26 2020-09-28 Evonik Operations Gmbh Etanol hatásával szemben ellenálló gyógyászati vagy táplálék-gyógyszerészeti kompozíció
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Also Published As

Publication number Publication date
HUP0101514A3 (en) 2003-07-28
IL139072A0 (en) 2001-11-25
NO20005223D0 (no) 2000-10-17
PL343634A1 (en) 2001-08-27
NO20005223L (no) 2000-11-20
EP1071432A1 (fr) 2001-01-31
HUP0101514A2 (hu) 2001-11-28
JP2002512195A (ja) 2002-04-23
CA2234936A1 (fr) 1999-10-17
CA2234936C (fr) 2004-06-29

Similar Documents

Publication Publication Date Title
US6046179A (en) Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
US9782348B2 (en) Ingestible formulations for transient, noninvasive reduction of gastric volume
Chen et al. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities
RU2681930C2 (ru) Применение андрографолида в получении фармацевтического препарата для лечения воспалительного заболевания кишечника, микропеллета с андрографолидом для целенаправленной доставки в кишечник и способ ее получения
JP2018087217A (ja) 排尿頻度を減少させるための延長放出製剤およびその使用の方法
Demirbilek et al. Effects of estradiol and progesterone on the synthesis of collagen in corrosive esophageal burns in rats
JP2015510928A (ja) 排尿頻度を減少させるための延長放出製剤およびその使用方法
CZ20003846A3 (cs) Kompozice pro léčbu zánětlivého onemocnění střev dávkováním N-acetylglukosaminu do tlustého střeva
JP5404406B2 (ja) 細胞外マトリクスの分解の阻害
JP2702400B2 (ja) 糖尿病性腎症治療用スロデキサイド含有医薬
JP2018039831A (ja) 排尿頻度を減少させるための医薬製剤およびその使用の方法
TWI516285B (zh) 含聚葡萄糖胺的劑型
EP4157998A1 (fr) Gel destiné à être utilisé en endoscopie gastro-intestinale et autres utilisations endodermiques, épidermiques et muqueuses
KR100375003B1 (ko) 배뇨장애 치료제
Jain et al. Alternative colon targeted drug delivery approaches for the treatment of inflammatory bowel disease
TWI446915B (zh) 玻尿酸混合物用於製造治療或預防黏膜相關病變或疾病之組成物的用途
US20160151296A1 (en) Long delayed release laxative
Asteria et al. Multiple enterocolic perforations and their possible association with prolonged intake of nimesulide: report of two cases
Das Pharmacotherapy of inflammatory bowel disease
Kulkarni et al. CODES TECHNOLOGY: A NOVEL APPROACH FOR COLON TARGET-A REVIEW ARTICLE
EP1100481A2 (fr) Formulations pharmaceutiques servant a traiter la maladie intestinale inflammatoire
Bell Drugs used in the management of gallstones
Kiran et al. COLO TARGETED DRUG DELIVERY SYSTEMS: OVEL APPROACHES
Singh et al. A Review Study on Novel Drug Delivery System for Colon Targeting
Christian Megacolon and an abdominal mass: 732